Codexis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.

About CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. 

CEO
Alison Moore
CEOAlison Moore
Employees
146
Employees146
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2002
Founded2002
Employees
146
Employees146

CDXS Key Statistics

Market cap
245.35M
Market cap245.35M
Price-Earnings ratio
-4.98
Price-Earnings ratio-4.98
Dividend yield
Dividend yield
Average volume
1.42M
Average volume1.42M
High today
$2.75
High today$2.75
Low today
$2.56
Low today$2.56
Open price
$2.61
Open price$2.61
Volume
428.21K
Volume428.21K
52 Week high
$3.87
52 Week high$3.87
52 Week low
$0.9583
52 Week low$0.9583

Stock Snapshot

With a market cap of 245.35M, Codexis(CDXS) trades at $2.70. The stock has a price-to-earnings ratio of -4.98.

On 2026-05-08, Codexis(CDXS) stock traded between a low of $2.56 and a high of $2.75. Shares are currently priced at $2.70, which is +5.5% above the low and -1.8% below the high.

The Codexis(CDXS)'s current trading volume is 428.21K, compared to an average daily volume of 1.42M.

In the last year, Codexis(CDXS) shares hit a 52-week high of $3.87 and a 52-week low of $0.96.

In the last year, Codexis(CDXS) shares hit a 52-week high of $3.87 and a 52-week low of $0.96.

CDXS News

TipRanks 14h
Codexis: Neutral Stance Maintained as Execution Risks Offset Solid Q1; $2 Price Target Reaffirmed

Codexis, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Brendan Smith from TD Cowen maintained a Hold rating on the st...

TipRanks 16h
Codexis reports Q1 EPS (10c), consensus (10c)

Reports Q1 revenue $15.25M, consensus $14.53M. “Next week Codexis (CDXS) will present new data at the TIDES USA annual meeting demonstrating how the ECO Synthes...

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

People also own

Based on the portfolios of people who own CDXS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.